Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brunangelo Falini

Showing results (181-190 of 246) with videos related to

Pageof 25
Sort By:
Leukemia & Lymphoma|June 4, 2011
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic courseFabio Forghieri, Monica Morselli, Leonardo Potenza, et al.
Blood|March 6, 2010
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)Brunangelo Falini, Katja Macijewski, Tamara Weiss, et al.
British Journal of Haematology|May 2, 2022
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfallMaria Stefania De Propris, Paolo Musiu, Stefania Intoppa, et al.
Blood Advances|February 14, 2022
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectivenessChiara Pirillo, Flora Birch, Floriane S Tissot, et al.
Cancer Cell|September 12, 2018
Mutant NPM1 Maintains the Leukemic State through HOX ExpressionLorenzo Brunetti, Michael C Gundry, Daniele Sorcini, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2008
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosminRamiro Garzon, Michela Garofalo, Maria Paola Martelli, et al.
Blood|June 14, 2014
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapseMassimo F Martelli, Mauro Di Ianni, Loredana Ruggeri, et al.
International Journal of Molecular Sciences|July 13, 2024
Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen ReceptorsNico Martarelli, Michela Capurro, Gizem Mansour, et al.
Clinical Case Reports|December 17, 2016
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with <i>NPM1</i>-mutated AML unfit for intensive chemotherapy and review of the literatureFabio Forghieri, Sara Bigliardi, Chiara Quadrelli, et al.
The American Journal of Pathology|January 1, 2003
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulinsStefano A Pileri, Gianluca Gaidano, Pier Luigi Zinzani, et al.
Pageof 25

Showing results (181-190 of 246) with videos related to

Sort By:
Pageof 25
Leukemia & Lymphoma|June 4, 2011
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic courseFabio Forghieri, Monica Morselli, Leonardo Potenza, et al.
Blood|March 6, 2010
Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1)Brunangelo Falini, Katja Macijewski, Tamara Weiss, et al.
British Journal of Haematology|May 2, 2022
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfallMaria Stefania De Propris, Paolo Musiu, Stefania Intoppa, et al.
Blood Advances|February 14, 2022
Metalloproteinase inhibition reduces AML growth, prevents stem cell loss, and improves chemotherapy effectivenessChiara Pirillo, Flora Birch, Floriane S Tissot, et al.
Cancer Cell|September 12, 2018
Mutant NPM1 Maintains the Leukemic State through HOX ExpressionLorenzo Brunetti, Michael C Gundry, Daniele Sorcini, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2008
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosminRamiro Garzon, Michela Garofalo, Maria Paola Martelli, et al.
Blood|June 14, 2014
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapseMassimo F Martelli, Mauro Di Ianni, Loredana Ruggeri, et al.
International Journal of Molecular Sciences|July 13, 2024
Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen ReceptorsNico Martarelli, Michela Capurro, Gizem Mansour, et al.
Clinical Case Reports|December 17, 2016
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with <i>NPM1</i>-mutated AML unfit for intensive chemotherapy and review of the literatureFabio Forghieri, Sara Bigliardi, Chiara Quadrelli, et al.
The American Journal of Pathology|January 1, 2003
Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1, and PU.1 in the absence of immunoglobulinsStefano A Pileri, Gianluca Gaidano, Pier Luigi Zinzani, et al.
Pageof 25